Pipecolic Acids
-
Subject Areas on Research
- Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia.
- American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
- Anticoagulant therapy in unstable angina.
- Anticoagulation in acute cardiac care in patients with chronic kidney disease.
- Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII.
- Argatroban and Bivalirudin for Perioperative Anticoagulation in Cardiac Surgery.
- Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
- Argatroban for anticoagulation during cardiopulmonary bypass in an infant.
- Comparison of the potency of competitive NMDA antagonists against the neurotoxicity of glutamate and NMDA.
- Concentration-Dependent Dual Role of Thrombin in Protection of Cultured Rat Cortical Neurons.
- Direct thrombin inhibitors: alternatives to heparin.
- Effects of NMDA receptor antagonists and body temperature in the gerbil carotid occlusion model of transient forebrain ischemia.
- Estimating data transformations in nonlinear mixed effects models.
- Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II.
- Glutamatergic antagonism: effects on lidocaine-induced seizures in the rat.
- Heparin-induced thrombocytopenia and cardiac surgery.
- Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation.
- Interactions between NMDA and AMPA glutamate receptor antagonists during halothane anesthesia in the rat.
- Local drug delivery of argatroban from a polymeric-metallic composite stent reduces platelet deposition in a swine coronary model.
- Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and future trials.
- Monitoring direct thrombin inhibitors: time for standardization.
- Multifocal electroretinogram in rhodopsin P347L transgenic pigs.
- NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro.
- New treatment options for heparin-induced thrombocytopenia.
- Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
- Pharmacologically defined components of the normal porcine multifocal ERG.
- Prevalence of ALDH7A1 mutations in 18 North American pyridoxine-dependent seizure (PDS) patients.
- Pyridoxine-dependent seizures: new genetic and biochemical clues to help with diagnosis and treatment.
- Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
- Regionally selective effects of NMDA receptor antagonists against ischemic brain damage in the gerbil.
- Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial.
- Scanning electron microscopical observations of two novel hemostatic polymers.
- Simultaneous determination of alpha-aminoadipic semialdehyde, piperideine-6-carboxylate and pipecolic acid by LC-MS/MS for pyridoxine-dependent seizures and folinic acid-responsive seizures.
- The effects of argatroban on thrombin generation and hemostatic activation in vitro.